Progress in classification and treatment for TNF receptor-associated periodic syndrome

Japanese Journal of Clinical Immunology

Volumn 34, Issue 5, 2011, Pages 361-368

  Tsukamoto, Hiroshi ^a   Ueda, Naoyasu ^a   Horiuchi, Takahiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Autoinflammatory syndrome; Etanercept; Misfolding; TNF; TNF receptor

Indexed keywords

CYTOKINE; ETANERCEPT; GLUCOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ABDOMINAL PAIN; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ERYTHEMA; GENE MUTATION; GENETIC ASSOCIATION; HEALTH SURVEY; HUMAN; JAPAN; MOLECULAR MODEL; MYALGIA; PERIORBITAL EDEMA; PROTEIN FOLDING; PROTEIN LOCALIZATION; RASH; RECURRENT FEVER; THORAX PAIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

ANTIBODIES, MONOCLONAL, HUMANIZED; CYTOKINES; GLUCOCORTICOIDS; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR TARGETED THERAPY; MUTATION; PROTEIN FOLDING; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SYNDROME; TOLL-LIKE RECEPTORS;

EID: 80455162570     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.34.361     Document Type: Article

References (24)

1. Bazzoni, F. and Beutler, B.: The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725, 1996.
2. Hull, K.M., et al.: The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81: 349-368, 2002.
3. Williamson, L. M., et al.: Familial Hibernian fever. Q. J. Med. 51: 469-480, 1982.
4. McDermott, M. F., et al.: Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97: 133-144, 1999.
5. Horiuchi, T., et al.: Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology 49: 1215-1228, 2010.
6. Aggarwal, B. B.,: Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756, 2003.
7. Varfolomeev E. E. and Ashkenazi, A.: Tumor necrosis factor: an apoptosis JuNKie? Cell 116: 491-497, 2004.
8. Kimberley, F. C., et al.: Falling into TRAPS-receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res. Ther. 9: 217, 2007.
9. Takagi, K., et al.: Tumor necrosis factor receptor-associated periodic syndrome with a C30R mutation in a Japanese family. Mod. Rheumatol. 17: 265-266, 2007.
10. Manki, A., et al.: Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. Allergol. Int. 55: 337-341, 2006.
11. Ida, H., et al.: A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology (Oxford) 43: 1292-1299, 2004.
12. Kusuhara, K., et al.: Tumour necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur. J. Pediatr. 163: 30-32, 2004.
13. Horiuchi, T., et al.: Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int. J. Mol. Med. 14: 813-818, 2004.
14. Japanese Sources
15. Nakamura, M., et al.: A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients. Br. J. Dermatol. 161: 968-970, 2009.
16. Stojanov, S., et al.: Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann. Rheum. Dis. 67: 1292-1298, 2008.
17. Lobito, A. A., et al.: Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108: 1320-1327, 2006.
18. D'Osualdo, A., et al.: Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum. 54: 998-1008, 2006.
19. Bulua, A. C., et al.: Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS), J. Exp. Med. 208: 519-533, 2011.
20. Simon, A., et al.: Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc. Natl. Acad. Sci. U.S.A. 107: 9801-9806, 2010.
21. Japanese Sources
22. Jacobelli, S., et al.: Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS). Rheumatology (Oxford) 46: 1211-1212, 2007.
23. Gattorno, M., et al.: Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 58: 1516-1520, 2008.
24. Vaitla, P. M., et al.: Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum. 63: 151-1155, 2011.